APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Cardiopulmonary Autotransfusion System

Cardiopulmonary Autotransfusion System is a sophisticated device with an exceptionally effective design that provides autologous blood during surgical procedures.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Cardiopulmonary Autotransfusion System is a sophisticated device with an exceptionally effective design that provides autologous blood during surgical procedures.

Autotransfusion is a process wherein a person receives their own blood for a transfusion, instead of banked allogenic (separate-donor) blood. There are two main kinds of Autotransfusion: Blood can be autologous "pre-donated" (termed so despite "donation" not typically referring to giving to one's self) before a surgery, or alternatively, it can be collected during and after the surgery using an intraoperative blood salvage device. The latter form of Autotransfusion is utilized in surgeries where there is expected a large volume blood loss.

Selected research

Industry Growth & Trends

Global Cardiopulmonary Autotransfusion System Industry Growth and Trends Forecast to 2032

Report ID 17390000011 January 202693 pages

Choose your research edition.

Industry ResearchCardiopulmonary Autotransfusion System Industry Research Report 2026122 pages · $2,950 USDIndustry Growth & TrendsGlobal Cardiopulmonary Autotransfusion System Industry Growth and Trends Forecast to 203293 pages · $3,450 USDMarket StructureGlobal Cardiopulmonary Autotransfusion System Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032181 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Cardiopulmonary Autotransfusion System Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal Cardiopulmonary Autotransfusion System Market Analysis and Forecast 2026-2032191 pages · $4,950 USD

Market perspective

Cardiopulmonary Autotransfusion System is a sophisticated device with an exceptionally effective design that provides autologous blood during surgical procedures.

Autotransfusion is a process wherein a person receives their own blood for a transfusion, instead of banked allogenic (separate-donor) blood. There are two main kinds of Autotransfusion: Blood can be autologous "pre-donated" (termed so despite "donation" not typically referring to giving to one's self) before a surgery, or alternatively, it can be collected during and after the surgery using an intraoperative blood salvage device. The latter form of Autotransfusion is utilized in surgeries where there is expected a large volume blood loss.

The major players in global Cardiopulmonary Autotransfusion System market include Haemonetics, Medtronic, LivaNova, etc. The top 3 players occupy about 70% shares of the global market. North America and Europe are main markets, they occupy about 80% of the global market. Washed ATS is the main type, with a share about 90%. Heart Surgery is the main application, which holds a share about 35%.

Read the full market overview

Report Scope

This report provides a structured, data-driven view of the global Cardiopulmonary Autotransfusion System market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Cardiopulmonary Autotransfusion System market size, estimates, and forecasts are presented in terms of sales volume (Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Cardiopulmonary Autotransfusion System market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Cardiopulmonary Autotransfusion System.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Cardiopulmonary Autotransfusion System market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Cardiopulmonary Autotransfusion System Market by Company

Haemonetics

Medtronic

LivaNova

Fresenius Kabi

Terumo

Wandong Health Sources

Cardiopulmonary Autotransfusion System Segment by Type

Unwashed ATS

Washed ATS

Cardiopulmonary Autotransfusion System Segment by Application

Heart Surgery

Great Organ Transplant Surgery

Other Surgery

Cardiopulmonary Autotransfusion System Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Cardiopulmonary Autotransfusion System market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Cardiopulmonary Autotransfusion System and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Cardiopulmonary Autotransfusion System.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Cardiopulmonary Autotransfusion System manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Cardiopulmonary Autotransfusion System in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Unwashed ATS Table 2. Major Company of Washed ATS Table 3. Global Cardiopulmonary Autotransfusion System Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Cardiopulmonary Autotransfusion System Sales by Type (2021-2026) & (Units) Table 5. Global Cardiopulmonary Autotransfusion System Sales Market Share in Volume by Type (2021-2026) Table 6. Global Cardiopulmonary Autotransfusion System Sales by Type (2021-2026) & (US$ Million) Table 7. Global Cardiopulmonary Autotransfusion System Sales Market Share in Value by Type (2021-2026) Table 8. Global Cardiopulmonary Autotransfusion System Price by Type (2021-2026) & (K US$/Unit) Table 9. Global Cardiopulmonary Autotransfusion System Sales by Type (2027-2032) & (Units) Table 10. Global Cardiopulmonary Autotransfusion System Sales Market Share in Volume by Type (2027-2032) Table 11. Global Cardiopulmonary Autotransfusion System Sales by Type (2027-2032) & (US$ Million) Table 12. Global Cardiopulmonary Autotransfusion System Sales Market Share in Value by Type (2027-2032) Table 13. Global Cardiopulmonary Autotransfusion System Price by Type (2027-2032) & (K US$/Unit) Table 14. North America Cardiopulmonary Autotransfusion System Sales by Type (2021-2026) & (Units) Table 15. North America Cardiopulmonary Autotransfusion System Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Cardiopulmonary Autotransfusion System Sales by Type (2021-2026) & (Units) Table 17. Europe Cardiopulmonary Autotransfusion System Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Cardiopulmonary Autotransfusion System Sales by Type (2021-2026) & (Units) Table 19. Asia-Pacific Cardiopulmonary Autotransfusion System Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Cardiopulmonary Autotransfusion System Sales by Type (2021-2026) & (Units) Table 21. Latin America Cardiopulmonary Autotransfusion System Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Cardiopulmonary Autotransfusion System Sales by Type (2021-2026) & (Units) Table 23. Middle East and Africa Cardiopulmonary Autotransfusion System Sales by Type (2021-2026) & (US$ Million) Table 24. Cardiopulmonary Autotransfusion System Industry Trends Table 25. Cardiopulmonary Autotransfusion System Industry Drivers Table 26. Cardiopulmonary Autotransfusion System Industry Opportunities and Challenges Table 27. Cardiopulmonary Autotransfusion System Industry Restraints Table 28. Global Cardiopulmonary Autotransfusion System Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Cardiopulmonary Autotransfusion System Revenue Market Share by Company (2021-2026) Table 30. Global Cardiopulmonary Autotransfusion System Sales by Company (2021-2026) & (Units) Table 31. Global Cardiopulmonary Autotransfusion System Sales Share by Company (2021-2026) Table 32. Global Cardiopulmonary Autotransfusion System Market Price by Company (2021-2026) & (K US$/Unit) Table 33. Global Cardiopulmonary Autotransfusion System Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Cardiopulmonary Autotransfusion System Major Company Production Sites and Headquarters Table 35. Global Cardiopulmonary Autotransfusion System Company, Product Type & Application Table 36. Global Cardiopulmonary Autotransfusion System Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Cardiopulmonary Autotransfusion System by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Cardiopulmonary Autotransfusion System Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Cardiopulmonary Autotransfusion System Sales by Region (2021-2026) & (Units) Table 41. Global Cardiopulmonary Autotransfusion System Sales Market Share in Volume by Region (2021-2026) Table 42. Global Cardiopulmonary Autotransfusion System Sales by Region (2021-2026) & (US$ Million) Table 43. Global Cardiopulmonary Autotransfusion System Sales Market Share in Value by Region (2021-2026) Table 44. Global Cardiopulmonary Autotransfusion System Sales (Units), Value (US$ Million), Price (K US$/Unit) and Gross Margin (2021-2026) Table 45. Global Cardiopulmonary Autotransfusion System Sales by Region (2027-2032) & (Units) Table 46. Global Cardiopulmonary Autotransfusion System Sales Market Share in Volume by Region (2027-2032) Table 47. Global Cardiopulmonary Autotransfusion System Sales by Region (2027-2032) & (US$ Million) Table 48. Global Cardiopulmonary Autotransfusion System Sales Market Share in Value by Region (2027-2032) Table 49. Global Cardiopulmonary Autotransfusion System Sales (Units), Value (US$ Million), Price (K US$/Unit) and Gross Margin (2027-2032) Table 50. Global Cardiopulmonary Autotransfusion System Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Cardiopulmonary Autotransfusion System Sales by Application (2021-2026) & (Units) Table 52. Global Cardiopulmonary Autotransfusion System Sales Market Share in Volume by Application (2021-2026) Table 53. Global Cardiopulmonary Autotransfusion System Sales by Application (2021-2026) & (US$ Million) Table 54. Global Cardiopulmonary Autotransfusion System Sales Market Share in Value by Application (2021-2026) Table 55. Global Cardiopulmonary Autotransfusion System Price by Application (2021-2026) & (K US$/Unit) Table 56. Global Cardiopulmonary Autotransfusion System Sales by Application (2027-2032) & (Units) Table 57. Global Cardiopulmonary Autotransfusion System Sales Market Share in Volume by Application (2027-2032) Table 58. Global Cardiopulmonary Autotransfusion System Sales by Application (2027-2032) & (US$ Million) Table 59. Global Cardiopulmonary Autotransfusion System Sales Market Share in Value by Application (2027-2032) Table 60. Global Cardiopulmonary Autotransfusion System Price by Application (2027-2032) & (K US$/Unit) Table 61. North America Cardiopulmonary Autotransfusion System Sales by Application (2021-2026) & (Units) Table 62. North America Cardiopulmonary Autotransfusion System Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Cardiopulmonary Autotransfusion System Sales by Application (2021-2026) & (Units) Table 64. Europe Cardiopulmonary Autotransfusion System Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Cardiopulmonary Autotransfusion System Sales by Application (2021-2026) & (Units) Table 66. Asia-Pacific Cardiopulmonary Autotransfusion System Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Cardiopulmonary Autotransfusion System Sales by Application (2021-2026) & (Units) Table 68. Latin America Cardiopulmonary Autotransfusion System Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Cardiopulmonary Autotransfusion System Sales by Application (2021-2026) & (Units) Table 70. Middle East and Africa Cardiopulmonary Autotransfusion System Sales by Application (2021-2026) & (US$ Million) Table 71. Haemonetics Company Information Table 72. Haemonetics Business Overview Table 73. Haemonetics Cardiopulmonary Autotransfusion System Sales (Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2021-2026) Table 74. Haemonetics Cardiopulmonary Autotransfusion System Product Portfolio Table 75. Haemonetics Recent Development Table 76. Medtronic Company Information Table 77. Medtronic Business Overview Table 78. Medtronic Cardiopulmonary Autotransfusion System Sales (Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2021-2026) Table 79. Medtronic Cardiopulmonary Autotransfusion System Product Portfolio Table 80. Medtronic Recent Development Table 81. LivaNova Company Information Table 82. LivaNova Business Overview Table 83. LivaNova Cardiopulmonary Autotransfusion System Sales (Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2021-2026) Table 84. LivaNova Cardiopulmonary Autotransfusion System Product Portfolio Table 85. LivaNova Recent Development Table 86. Fresenius Kabi Company Information Table 87. Fresenius Kabi Business Overview Table 88. Fresenius Kabi Cardiopulmonary Autotransfusion System Sales (Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2021-2026) Table 89. Fresenius Kabi Cardiopulmonary Autotransfusion System Product Portfolio Table 90. Fresenius Kabi Recent Development Table 91. Terumo Company Information Table 92. Terumo Business Overview Table 93. Terumo Cardiopulmonary Autotransfusion System Sales (Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2021-2026) Table 94. Terumo Cardiopulmonary Autotransfusion System Product Portfolio Table 95. Terumo Recent Development Table 96. Wandong Health Sources Company Information Table 97. Wandong Health Sources Business Overview Table 98. Wandong Health Sources Cardiopulmonary Autotransfusion System Sales (Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2021-2026) Table 99. Wandong Health Sources Cardiopulmonary Autotransfusion System Product Portfolio Table 100. Wandong Health Sources Recent Development Table 101. North America Cardiopulmonary Autotransfusion System Market Size Growth Rate (CAGR) by Country (Units): 2021 VS 2025 VS 2032 Table 102. North America Cardiopulmonary Autotransfusion System Sales by Country (2021-2026) & (Units) Table 103. North America Cardiopulmonary Autotransfusion System Sales Market Share by Country (2021-2026) Table 104. North America Cardiopulmonary Autotransfusion System Sales Forecast by Country (2027-2032) & (Units) Table 105. North America Cardiopulmonary Autotransfusion System Sales Market Share Forecast by Country (2027-2032) Table 106. North America Cardiopulmonary Autotransfusion System Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 107. North America Cardiopulmonary Autotransfusion System Market Size by Country (2021-2026) & (US$ Million) Table 108. North America Cardiopulmonary Autotransfusion System Market Share by Country (2021-2026) Table 109. North America Cardiopulmonary Autotransfusion System Market Size Forecast by Country (2027-2032) & (US$ Million) Table 110. North America Cardiopulmonary Autotransfusion System Market Share Forecast by Country (2027-2032) Table 111. Europe Cardiopulmonary Autotransfusion System Market Size Growth Rate (CAGR) by Country (Units): 2021 VS 2025 VS 2032 Table 112. Europe Cardiopulmonary Autotransfusion System Sales by Country (2021-2026) & (Units) Table 113. Europe Cardiopulmonary Autotransfusion System Sales Market Share by Country (2021-2026) Table 114. Europe Cardiopulmonary Autotransfusion System Sales Forecast by Country (2027-2032) & (Units) Table 115. Europe Cardiopulmonary Autotransfusion System Sales Market Share Forecast by Country (2027-2032) Table 116. Europe Cardiopulmonary Autotransfusion System Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 117. Europe Cardiopulmonary Autotransfusion System Market Size by Country (2021-2026) & (US$ Million) Table 118. Europe Cardiopulmonary Autotransfusion System Market Share by Country (2021-2026) Table 119. Europe Cardiopulmonary Autotransfusion System Market Size Forecast by Country (2027-2032) & (US$ Million) Table 120. Europe Cardiopulmonary Autotransfusion System Market Share Forecast by Country (2027-2032) Table 121. Asia-Pacific Cardiopulmonary Autotransfusion System Market Size Growth Rate (CAGR) by Country (Units): 2021 VS 2025 VS 2032 Table 122. Asia-Pacific Cardiopulmonary Autotransfusion System Sales by Country (2021-2026) & (Units) Table 123. Asia-Pacific Cardiopulmonary Autotransfusion System Sales Market Share by Country (2021-2026) Table 124. Asia-Pacific Cardiopulmonary Autotransfusion System Sales Forecast by Country (2027-2032) & (Units) Table 125. Asia-Pacific Cardiopulmonary Autotransfusion System Sales Market Share Forecast by Country (2027-2032) Table 126. Asia-Pacific Cardiopulmonary Autotransfusion System Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 127. Asia-Pacific Cardiopulmonary Autotransfusion System Market Size by Country (2021-2026) & (US$ Million) Table 128. Asia-Pacific Cardiopulmonary Autotransfusion System Market Share by Country (2021-2026) Table 129. Asia-Pacific Cardiopulmonary Autotransfusion System Market Size Forecast by Country (2027-2032) & (US$ Million) Table 130. Asia-Pacific Cardiopulmonary Autotransfusion System Market Share Forecast by Country (2027-2032) Table 131. Latin America Cardiopulmonary Autotransfusion System Market Size Growth Rate (CAGR) by Country (Units): 2021 VS 2025 VS 2032 Table 132. Latin America Cardiopulmonary Autotransfusion System Sales by Country (2021-2026) & (Units) Table 133. Latin America Cardiopulmonary Autotransfusion System Sales Market Share by Country (2021-2026) Table 134. Latin America Cardiopulmonary Autotransfusion System Sales Forecast by Country (2027-2032) & (Units) Table 135. Latin America Cardiopulmonary Autotransfusion System Sales Market Share Forecast by Country (2027-2032) Table 136. Latin America Cardiopulmonary Autotransfusion System Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 137. Latin America Cardiopulmonary Autotransfusion System Market Size by Country (2021-2026) & (US$ Million) Table 138. Latin America Cardiopulmonary Autotransfusion System Market Share by Country (2021-2026) Table 139. Latin America Cardiopulmonary Autotransfusion System Market Size Forecast by Country (2027-2032) & (US$ Million) Table 140. Latin America Cardiopulmonary Autotransfusion System Market Share Forecast by Country (2027-2032) Table 141. Middle East and Africa Cardiopulmonary Autotransfusion System Market Size Growth Rate (CAGR) by Country (Units): 2021 VS 2025 VS 2032 Table 142. Middle East and Africa Cardiopulmonary Autotransfusion System Sales by Country (2021-2026) & (Units) Table 143. Middle East and Africa Cardiopulmonary Autotransfusion System Sales Market Share by Country (2021-2026) Table 144. Middle East and Africa Cardiopulmonary Autotransfusion System Sales Forecast by Country (2027-2032) & (Units) Table 145. Middle East and Africa Cardiopulmonary Autotransfusion System Sales Market Share Forecast by Country (2027-2032) Table 146. Middle East and Africa Cardiopulmonary Autotransfusion System Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 147. Middle East and Africa Cardiopulmonary Autotransfusion System Market Size by Country (2021-2026) & (US$ Million) Table 148. Middle East and Africa Cardiopulmonary Autotransfusion System Market Share by Country (2021-2026) Table 149. Middle East and Africa Cardiopulmonary Autotransfusion System Market Size Forecast by Country (2027-2032) & (US$ Million) Table 150. Middle East and Africa Cardiopulmonary Autotransfusion System Market Share Forecast by Country (2027-2032) Table 151. Key Raw Materials Table 152. Raw Materials Key Suppliers Table 153. Cardiopulmonary Autotransfusion System Distributors List Table 154. Cardiopulmonary Autotransfusion System Customers List Table 155. Research Programs/Design for This Report Table 156. Authors List of This Report Table 157. Secondary Sources Table 158. Primary Sources List of Figures Figure 1. Cardiopulmonary Autotransfusion System Image Figure 2. Global Cardiopulmonary Autotransfusion System Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Cardiopulmonary Autotransfusion System Market Size (2021-2032) & (US$ Million) Figure 4. Global Cardiopulmonary Autotransfusion System Sales (2021-2032) & (Units) Figure 5. Unwashed ATS Image Figure 6. Global Unwashed ATS Sales YoY Growth (2021-2032) & (Units) Figure 7. Washed ATS Image Figure 8. Global Washed ATS Sales YoY Growth (2021-2032) & (Units) Figure 9. Global Cardiopulmonary Autotransfusion System Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Cardiopulmonary Autotransfusion System Market Share by Type 2025 VS 2032 Figure 11. North America Cardiopulmonary Autotransfusion System Sales Market Share in Volume by Type in 2025 Figure 12. North America Cardiopulmonary Autotransfusion System Sales Market Share in Value by Type in 2025 Figure 13. Europe Cardiopulmonary Autotransfusion System Sales Market Share in Volume by Type in 2025 Figure 14. Europe Cardiopulmonary Autotransfusion System Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Cardiopulmonary Autotransfusion System Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Cardiopulmonary Autotransfusion System Sales Market Share in Value by Type in 2025 Figure 17. Latin America Cardiopulmonary Autotransfusion System Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Cardiopulmonary Autotransfusion System Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Cardiopulmonary Autotransfusion System Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Cardiopulmonary Autotransfusion System Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Cardiopulmonary Autotransfusion System Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Heart Surgery Image Figure 24. Global Heart Surgery Sales YoY Growth (2021-2032) & (Units) Figure 25. Great Organ Transplant Surgery Image Figure 26. Global Great Organ Transplant Surgery Sales YoY Growth (2021-2032) & (Units) Figure 27. Other Surgery Image Figure 28. Global Other Surgery Sales YoY Growth (2021-2032) & (Units) Figure 29. Global Cardiopulmonary Autotransfusion System Market Size Overview by Application (2021-2032) & (US$ Million) Figure 30. Global Cardiopulmonary Autotransfusion System Market Share by Application 2025 VS 2032 Figure 31. North America Cardiopulmonary Autotransfusion System Sales Market Share in Volume by Application in 2025 Figure 32. North America Cardiopulmonary Autotransfusion System Sales Market Share in Value by Application in 2025 Figure 33. Europe Cardiopulmonary Autotransfusion System Sales Market Share in Volume by Application in 2025 Figure 34. Europe Cardiopulmonary Autotransfusion System Sales Market Share in Value by Application in 2025 Figure 35. Asia-Pacific Cardiopulmonary Autotransfusion System Sales Market Share in Volume by Application in 2025 Figure 36. Asia-Pacific Cardiopulmonary Autotransfusion System Sales Market Share in Value by Application in 2025 Figure 37. Latin America Cardiopulmonary Autotransfusion System Sales Market Share in Volume by Application in 2025 Figure 38. Latin America Cardiopulmonary Autotransfusion System Sales Market Share in Value by Application in 2025 Figure 39. Middle East and Africa Cardiopulmonary Autotransfusion System Sales Market Share in Volume by Application in 2025 Figure 40. Middle East and Africa Cardiopulmonary Autotransfusion System Sales Market Share in Value by Application in 2025 Figure 41. North America Cardiopulmonary Autotransfusion System Sales by Country: 2021 VS 2025 VS 2032 (Units) Figure 42. North America Cardiopulmonary Autotransfusion System Sales Share by Country: 2021 VS 2025 VS 2032 Figure 43. North America Cardiopulmonary Autotransfusion System Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 44. North America Cardiopulmonary Autotransfusion System Market Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Cardiopulmonary Autotransfusion System Sales by Country: 2021 VS 2025 VS 2032 (Units) Figure 46. Europe Cardiopulmonary Autotransfusion System Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Cardiopulmonary Autotransfusion System Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Europe Cardiopulmonary Autotransfusion System Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Cardiopulmonary Autotransfusion System Sales by Country: 2021 VS 2025 VS 2032 (Units) Figure 50. Asia-Pacific Cardiopulmonary Autotransfusion System Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Cardiopulmonary Autotransfusion System Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Asia-Pacific Cardiopulmonary Autotransfusion System Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Cardiopulmonary Autotransfusion System Sales by Country: 2021 VS 2025 VS 2032 (Units) Figure 54. Latin America Cardiopulmonary Autotransfusion System Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Cardiopulmonary Autotransfusion System Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Latin America Cardiopulmonary Autotransfusion System Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Cardiopulmonary Autotransfusion System Sales by Country: 2021 VS 2025 VS 2032 (Units) Figure 58. Middle East and Africa Cardiopulmonary Autotransfusion System Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Cardiopulmonary Autotransfusion System Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Middle East and Africa Cardiopulmonary Autotransfusion System Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Cardiopulmonary Autotransfusion System Value Chain Figure 62. Key Raw Materials Price Figure 63. Manufacturing Cost Structure Figure 64. Cardiopulmonary Autotransfusion System Production Mode & Process Figure 65. Direct Comparison with Distribution Share Figure 66. Distributors Profiles Figure 67. Years Considered Figure 68. Research Process Figure 69. Key Executives Interviewed

Scope & coverage.

Types
  • Unwashed ATS
  • Washed ATS
Applications
  • Heart Surgery
  • Great Organ Transplant Surgery
  • Other Surgery
Companies covered
  • Haemonetics
  • Medtronic
  • LivaNova
  • Fresenius Kabi
  • Terumo
  • Wandong Health Sources

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Cardiopulmonary Autotransfusion System Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Cardiopulmonary Autotransfusion System Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Cardiopulmonary Autotransfusion System Market by Type
  6. 1.3.1 Unwashed ATS
  7. 1.3.2 Washed ATS
  8. 1.4 Global Cardiopulmonary Autotransfusion System Market Size by Type
  9. 1.4.1 Global Cardiopulmonary Autotransfusion System Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Cardiopulmonary Autotransfusion System Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Cardiopulmonary Autotransfusion System Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Cardiopulmonary Autotransfusion System Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Cardiopulmonary Autotransfusion System Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Cardiopulmonary Autotransfusion System Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Cardiopulmonary Autotransfusion System Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Cardiopulmonary Autotransfusion System Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Cardiopulmonary Autotransfusion System Industry Trends
  2. 2.2 Cardiopulmonary Autotransfusion System Industry Drivers
  3. 2.3 Cardiopulmonary Autotransfusion System Industry Opportunities and Challenges
  4. 2.4 Cardiopulmonary Autotransfusion System Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Cardiopulmonary Autotransfusion System Revenue (2021-2026)
  2. 3.2 Global Top Players by Cardiopulmonary Autotransfusion System Sales (2021-2026)
  3. 3.3 Global Top Players by Cardiopulmonary Autotransfusion System Price (2021-2026)
  4. 3.4 Global Cardiopulmonary Autotransfusion System Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Cardiopulmonary Autotransfusion System Major Company Production Sites & Headquarters
  6. 3.6 Global Cardiopulmonary Autotransfusion System Company, Product Type & Application
  7. 3.7 Global Cardiopulmonary Autotransfusion System Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Cardiopulmonary Autotransfusion System Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Cardiopulmonary Autotransfusion System Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Cardiopulmonary Autotransfusion System Tier 1, Tier 2, and Tier 3
4 Cardiopulmonary Autotransfusion System Regional Status and Outlook
  1. 4.1 Global Cardiopulmonary Autotransfusion System Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Cardiopulmonary Autotransfusion System Historic Market Size by Region
  3. 4.2.1 Global Cardiopulmonary Autotransfusion System Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Cardiopulmonary Autotransfusion System Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Cardiopulmonary Autotransfusion System Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Cardiopulmonary Autotransfusion System Forecasted Market Size by Region
  7. 4.3.1 Global Cardiopulmonary Autotransfusion System Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Cardiopulmonary Autotransfusion System Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Cardiopulmonary Autotransfusion System Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Cardiopulmonary Autotransfusion System by Application
  1. 5.1 Cardiopulmonary Autotransfusion System Market by Application
  2. 5.1.1 Heart Surgery
  3. 5.1.2 Great Organ Transplant Surgery
  4. 5.1.3 Other Surgery
  5. 5.2 Global Cardiopulmonary Autotransfusion System Market Size by Application
  6. 5.2.1 Global Cardiopulmonary Autotransfusion System Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Cardiopulmonary Autotransfusion System Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Cardiopulmonary Autotransfusion System Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Cardiopulmonary Autotransfusion System Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Cardiopulmonary Autotransfusion System Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Cardiopulmonary Autotransfusion System Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Cardiopulmonary Autotransfusion System Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Cardiopulmonary Autotransfusion System Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Haemonetics
  2. 6.1.1 Haemonetics Company Information
  3. 6.1.2 Haemonetics Business Overview
  4. 6.1.3 Haemonetics Cardiopulmonary Autotransfusion System Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Haemonetics Cardiopulmonary Autotransfusion System Product Portfolio
  6. 6.1.5 Haemonetics Recent Developments
  7. 6.2 Medtronic
  8. 6.2.1 Medtronic Company Information
  9. 6.2.2 Medtronic Business Overview
  10. 6.2.3 Medtronic Cardiopulmonary Autotransfusion System Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Medtronic Cardiopulmonary Autotransfusion System Product Portfolio
  12. 6.2.5 Medtronic Recent Developments
  13. 6.3 LivaNova
  14. 6.3.1 LivaNova Company Information
  15. 6.3.2 LivaNova Business Overview
  16. 6.3.3 LivaNova Cardiopulmonary Autotransfusion System Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 LivaNova Cardiopulmonary Autotransfusion System Product Portfolio
  18. 6.3.5 LivaNova Recent Developments
  19. 6.4 Fresenius Kabi
  20. 6.4.1 Fresenius Kabi Company Information
  21. 6.4.2 Fresenius Kabi Business Overview
  22. 6.4.3 Fresenius Kabi Cardiopulmonary Autotransfusion System Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Fresenius Kabi Cardiopulmonary Autotransfusion System Product Portfolio
  24. 6.4.5 Fresenius Kabi Recent Developments
  25. 6.5 Terumo
  26. 6.5.1 Terumo Company Information
  27. 6.5.2 Terumo Business Overview
  28. 6.5.3 Terumo Cardiopulmonary Autotransfusion System Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Terumo Cardiopulmonary Autotransfusion System Product Portfolio
  30. 6.5.5 Terumo Recent Developments
  31. 6.6 Wandong Health Sources
  32. 6.6.1 Wandong Health Sources Company Information
  33. 6.6.2 Wandong Health Sources Business Overview
  34. 6.6.3 Wandong Health Sources Cardiopulmonary Autotransfusion System Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Wandong Health Sources Cardiopulmonary Autotransfusion System Product Portfolio
  36. 6.6.5 Wandong Health Sources Recent Developments
7 North America by Country
  1. 7.1 North America Cardiopulmonary Autotransfusion System Sales by Country
  2. 7.1.1 North America Cardiopulmonary Autotransfusion System Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Cardiopulmonary Autotransfusion System Sales by Country (2021-2026)
  4. 7.1.3 North America Cardiopulmonary Autotransfusion System Sales Forecast by Country (2027-2032)
  5. 7.2 North America Cardiopulmonary Autotransfusion System Market Size by Country
  6. 7.2.1 North America Cardiopulmonary Autotransfusion System Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Cardiopulmonary Autotransfusion System Market Size by Country (2021-2026)
  8. 7.2.3 North America Cardiopulmonary Autotransfusion System Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Cardiopulmonary Autotransfusion System Sales by Country
  2. 8.1.1 Europe Cardiopulmonary Autotransfusion System Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Cardiopulmonary Autotransfusion System Sales by Country (2021-2026)
  4. 8.1.3 Europe Cardiopulmonary Autotransfusion System Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Cardiopulmonary Autotransfusion System Market Size by Country
  6. 8.2.1 Europe Cardiopulmonary Autotransfusion System Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Cardiopulmonary Autotransfusion System Market Size by Country (2021-2026)
  8. 8.2.3 Europe Cardiopulmonary Autotransfusion System Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Cardiopulmonary Autotransfusion System Sales by Country
  2. 9.1.1 Asia-Pacific Cardiopulmonary Autotransfusion System Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Cardiopulmonary Autotransfusion System Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Cardiopulmonary Autotransfusion System Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Cardiopulmonary Autotransfusion System Market Size by Country
  6. 9.2.1 Asia-Pacific Cardiopulmonary Autotransfusion System Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Cardiopulmonary Autotransfusion System Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Cardiopulmonary Autotransfusion System Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Cardiopulmonary Autotransfusion System Sales by Country
  2. 10.1.1 South America Cardiopulmonary Autotransfusion System Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Cardiopulmonary Autotransfusion System Sales by Country (2021-2026)
  4. 10.1.3 South America Cardiopulmonary Autotransfusion System Sales Forecast by Country (2027-2032)
  5. 10.2 South America Cardiopulmonary Autotransfusion System Market Size by Country
  6. 10.2.1 South America Cardiopulmonary Autotransfusion System Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Cardiopulmonary Autotransfusion System Market Size by Country (2021-2026)
  8. 10.2.3 South America Cardiopulmonary Autotransfusion System Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Cardiopulmonary Autotransfusion System Sales by Country
  2. 11.1.1 Middle East and Africa Cardiopulmonary Autotransfusion System Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Cardiopulmonary Autotransfusion System Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Cardiopulmonary Autotransfusion System Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Cardiopulmonary Autotransfusion System Market Size by Country
  6. 11.2.1 Middle East and Africa Cardiopulmonary Autotransfusion System Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Cardiopulmonary Autotransfusion System Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Cardiopulmonary Autotransfusion System Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Cardiopulmonary Autotransfusion System Value Chain Analysis
  2. 12.1.1 Cardiopulmonary Autotransfusion System Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Cardiopulmonary Autotransfusion System Production Mode & Process
  7. 12.2 Cardiopulmonary Autotransfusion System Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Cardiopulmonary Autotransfusion System Distributors
  10. 12.2.3 Cardiopulmonary Autotransfusion System Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst